3 Third
30 / October/ 2020
International Symposiumon Advances in PCOSand Women’s Health
Second2 31 / October/ 2020
JOI
NT
MEETi
NG
&
ONLINE EDITION
Organized by
Serbian Society forReproductive Endocrinology
www.reproduktivna-endokrinologija.org.rs
Endorsed by
OrganizatorSrpsko društvo za reproduktivnu endokrinologiju
3rd International Symposium on Advancesin PCOS and Women’s Health
&
2nd Belgrade Masterclass in Clinical Endocrinology, Diabetes and Metabolism
PROGRAM
30-31. Oktobar 2020.
www.reproduktivna-endokrinologija.org.rs
1
Programski odbor PCOS & Women’s Health
Predsednik odbora
Prof. dr Đuro Macut, Srbija
Članovi odbora
Akademik Dragan Micić, Srbija
Professor Evanthia Diamanti Kandarakis, Greece
Professor Bulent Yildiz, Turkey
Professor George Mastorakos, Greece
Professor Blazej Meczekalski, Poland
Professor Alessandra Gambineri, Italy
Professor Duarte Pignatelli, Portugal
Ass Professor Sarantis Livadas, Greece
2
Programski odbor Masterclass
Predsednik odbora
Prof. dr Đuro Macut, Srbija
Članovi odbora
Akademik Nebojša Lalić, Srbija
Prof. dr Svetozar Damjanović, Srbija
Professor Gregory Kaltsas, Greece
Professor Tatjana Milenković, North Macedonia
Professor Dario Rahelić, Croatia
Professor Zelija Velija-Ašimi, Bosnia and Herzegovina
Professor Azra Bureković, Bosnia and Herzegovina
3
Organizacioni odbor
Predsednik odbora
Prof. dr Đuro Macut, Srbija
Članovi odbora
Asist. dr Sanja Ognjanović
Asist. dr Bojana Popović
Asist. dr Jelica Bjekić-Macut
Asist. dr Ivana Božić-Antić
Asist. dr Tatjana Isailović
dr Dušan Ilić
dr Tamara Bogavac
4
Opšte informacije
Mesto održavanja
Live stream na strani: www.reproduktivna-endokrinologija.org.rs
Registracija
Registracija je obavezna kako bi mogli da pristupite prenosu uživo i testovima. Samo učesnici koji su izmirili kotizaciju imaće pristup sadržaju. Svaki učesnik koji ispunjava uslove dobiće potvrdni email, i pristup sadržaju za koji je pretplaćen.
Kotizacija
Kotizacija za oba događaja iznosi 6.000,00 dinara.Kotizacija za jedan događaj, PCOS ili Masterclas, iznosi 4.200,00 dinaraKotizacija obuhvata pristup prenosu predavanja uživo, snimljenim predavanji-ma i testovima kada budu postavljeni posle događaja.
KME bodoviOba događaja će biti akreditovana kroz testove, koje ćete moći da polažete od sredine novembra. Obaveštenje ćete dobiti putem e-maila.
Važne adrese
IZVRŠNI ORGANIZATOR i SEKRETARIJAT SIMPOZIJUMA Dekon kongresТеlefoni:+381 64 4 5555 42; +381 11 675 3131e-mail: [email protected]: www.dekongroup.com
5
3 Third
30 / October/ 2020
International Symposiumon Advances in PCOSand Women’s Health
PROGRAM
08.15-08.30
Opening of the Symposium
Đuro Macut, SerbiaChair of the Programme and Organizing Committees
Nebojša Lalić, SerbiaDean of the Faculty of Medicine, University of Belgrade
08.30-09.00
Plenary Lecture 1CHAIRS: Nebojša Lalić, Đuro Macut
Metabolic surgery for women: current conceptsDragan Micić, Serbia
Advances in PCOSMODERATORS: George Mastorakos, Blazej Meczekalski
09.00-09.15Androgen excess and metabolic traits associated with PCOS: a lesson from animal model Danijela Vojnović Milutinović, Serbia
09.15-09.30Cardiometabolic risk in PCOS: role of androgens and insulin signalling pathways Đuro Macut, Serbia
09.30-09.45 Management of adolescent PCOSBlazej Meczekalski, Poland
09.45-10.00 Androgens and menopause: is it related to PCOS only? George Mastorakos, Greece
10.00-10.15 Discussion
6
Hyperandrogenic states – new approachMODERATORS: Bulent Yildiz, Alessandra Gambineri
11.00-11.15Sex hormones, weight and insulin: from reference levels to clinical appli-cation Alessandra Gambineri, Italy
11.15-11.30 Anti-Müllerian hormone: a diagnostic tool for PCOSBulent Yildiz, Turkey
11.30-11.45Genomics and the causal pathways in PCOS and hyperandrogenic statesDuarte Pignatelli, Portugal
11.45-12.00 Management of hyperandrogenism: Non-classical CAH vs. PCOSSarantis Livadas, Greece
12.00-12.15 Discussion
12.30-13.00 MITER International - Satellite SymposiumPCOS: Clinical relevance of Inositols treatment - Prof. Fabio Facchinetti
13.00-13.15 Alkaloid - Satellite SymposiumsAntioksidansi i infertilitet - Prof. dr Đuro Macut
13.15-14.30 Break
14.30-15.00
Plenary Lecture 2CHAIRS: Đuro Macut, Miloš Žarković
Potential COVID-19-related implications on aspects of polycystic ovary syndrome Evanthia Diamanti-Kandarakis, Greece
Challenging issues of infertility treatment in womenMODERATORS: Miloš Žarković, Predrag Miljić
15.00-15.15 Infertility treatments and outcomes in women Ana Mitrović Jovanović, Serbia
15.15-15.30Management of thyroid dysfunction during infertility treatments and pregnancy Miloš Žarković, Serbia
15.30-15.45 Thrombophilia screening for infertility in women: clinical relevancePredrag Miljić, Serbia
7
15.45-16.00 Imunological causes of recurrent miscarriagesVesna Mandić Marković, Serbia
16.00-16.15 Discussion
16.15-17.00 Break
New horizons in researchMODERATORS: Đuro Macut, Sarantis Livadas
17.00-17.10Prenatal androgenization and behavior: an insight from the animal modelAleksandra Rašić Marković, Serbia
17.10-17.20 Metabolic clustering to the phenotypes of adult PCOSIvana Božić Antić, Serbia
17.20-17.30 Adolescent PCOS: role for anthropometric and biochemical markers Ilijana Mažibrada, Serbia
17.30-17.40 Lifestyle intervention in adolescent girls with obesityLjiljana Plavšić, Serbia
17.40-17.50 Quality of life assessment in PCOS: development of the concept Dejan Stevanović, Serbia
17.50-18.15 Discussion
18.15 Closing of the Symposium
8
PROGRAM
08.45-09.00 Introduction Djuro Macut
09.00-09.30
NET Keynote LectureChairs: Svetozar Damjanović, Djuro Macut
Advances in the management of well-differentiated neuroendocrine neo-plasmsGregory Kaltsas, Greece
Panel
09.30-10.30
Small intestine neuroendocrine tumors – diagnostic and therapeutic approach
• Djuro Macut • Svetozar Damjanović • Marjan Micev• Dragutin Kecmanović• Nemanja Menković• Jelena Kovač
• Maja Pavlov• Davorin Radosavljević• Nebojša Petrović• Marina Vlajković• Marija Boričić
Workshop
11.00-11.45
NET Workshop
Moderators:• Sanja Ognjanović• Bojana Popović• Tatjana Isailović
Discussants:• Dušan Ilić• Branislava Radović• Tamara Bogavac• Ivana Bozić Antić
Second2 31 / October/ 2020
9
12.00-12.30Novartis - Satellite SymposiumNeuroendokrini tumori - Lekari sa Odeljenja za tumore endokrinog siste-ma i nasledne kancerske sindrome
12.30-12.45 Oktal pharma - Satellite SymposiumUloga D chiro inositola kod hiperinsulinemije - Prof. dr Đuro Macut
12.45-13.15 PharmaSwiss - Satellite SymposiumSomatostatinski analozi u lečenju GEP NET - Prof. dr Djuro Macut
13.30-14.15
SANOFI - Satellite SymposiumDijabetesna bolest bubrega-sadašnje stanje - Prof. dr Radomir Naumović
Insulinska terapija i dijabetesna bolest bubrega-subanaliza novih studija -Akademik Prof. dr Nebojša Lalić
14.30-15.00
Diabetes Keynote LectureChairs: Tatjana Milenković, Dario Rahelić
Treatment of hyperglycemia in type 2 diabetes – new recommendations 2020 Nebojša Lalić
Panel
15.00-16.00
Hypoglycemia in diabetes – risks and consequences
• Tatjana Milenković, N.Macedonia• Dario Rahelić, Croatia • Aleksandra Jotić• Jelica Bjekić Macut
• Marija Zdravković• Azra Bureković, Bosnia and Her-
zegovina• Zoran Todorović• Dragana Tomić-Naglić
16.15-16.45
NOVO NORDISK - Satellite SymposiumSavremene terapijske opcije u dijabetesu - prof dr Nebojša Lalić doc. dr Tanja Miličić doc. dr Ljiljana Lukić doc. dr Nataša Rajković
Panel
17.00-18.00
Diabetes – (not so) silent threat for the kidney
• Tatjana Milenković, N.Macedonia• Katarina Lalić• Slobodan Antić• Zelija Velija Asimi, Bosnia and
Herzegovina
• Milena Mitrović• Snežana Polovina• Milan Radović • Zoran Todorović
10
Workshop
18.00-18.45
Diabetes Workshop
Moderators: • Ljiljana Lukić• Zoran Gluvić• Đorđe Popović
Discussants:• Goran Cvijović• Saša Radenković
18.45 Closing of the Masterclass
11
SPONZORI
PRIJATELJI SIMPOZIJUMA
12
SAMO ZA STRUČNU JAVNOST.
MAT-RS-2000353 -1.0- 10/2020
Sanofi-Aventis d.o.o. Španskih boraca 3/VI 11000 Beograd Tel: +381 11 4422 900 Fax: +381 11 4422 924
insulin degludek
Pomozite vašim Pacijentima da
smanje rizik od hiPoglikemija1-3*
*Insulin degludek u poređenju sa insulin glarginom 100 j./mL
Broj dozvole za stavljanje leka u promet: Tresiba® FlexTouch® 100 jedinica/mL, rastvor za injekciju u penu sa uloškom 515-01-06134-13-001, datum: 29.12.2014.
Datum poslednje revizije teksta Sažetka karakteristika leka: februar, 2019
Referenca: 1. Marso, S. P. et al. (2017) Efficacy and safety of degludec versus glargine in type 2 diabetes. New England Journal of Medicine, 377(8), p.723-732. 2. Wysham, C. et al. (2017) Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 2 diabetes: the SWITCH 2 randomized clinical trial. Jama, 318(1), p.45-56. 3. Lane, W. et al. (2017) Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 1 diabetes: the SWITCH 1 randomized clinical trial. Jama, 318(1),p. 33-44.
Režim izdavanja leka: samo na lekarski recept
Za detaljnije informacije proučiti Sažetak karakteristika leka
Nosilac dozvole:Novo Nordisk Pharma d.o.o.Milutina Milankovića 9b11070 Beograd, SrbijaDatum pripreme materijala: mart 2019.
samo za strUČnU javnost
SM19
TSM
0000
6
Broj rešenja kojim se odobrava upotreba promotivnog materijala: 515-08-00160-19-001, od 01.07.2019. godine
16
18
19
